维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="Haraf D"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Pilot study examiningtumor expression of Rad51 and clinical outcomes in human headcancers显示文摘	Connell PP Jayathilaka K Haraf D]	2006	Int J Oncol2006，28，5：	1
	2	Phase Ⅰ study of bevacizumab added to fluorouracil-and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer显示文摘	SEIWERT T Y HARAF D J COHEN E E		0，，10：	1
	3	Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers显示文摘	CONNELL P P JAYATHILAKA K HARAF D J	2006	Int J Oncol2006，28，：	1
	4	Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer显示文摘	HASSELLE M D HARAF D J RUSTHOVEN K E		0，，02：	1
	5	Pilot study exami- ning tumor expression of RAD51 and clinical outcomes in human head cancers显示文摘	Connell P P Jayathilaka K Haraf D J	2006	Int J Oncol2006，28，5：	1
	6	Phase I study of bevacizumab added to fluorouracil-and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer显示文摘	Seiwert TY Haraf D J Cohen EE	2008	J Clin Oncol2008，26，10：	1
	7	Human papilloma vi- rus and p53 in head and neck cancer: clinical correlates and sur- vival显示文摘	Haraf DJ Nodzenski E Brachman D	1996	Clin Cancer Res1996，2，4：	1
	8	A phase Ⅰ trial of OSI 774 in combination with chemoradiation (CRT) for unresectable,locally advanced non-small cell lung cancer (NSCLC)显示文摘	Mauer A Haraf D Hoffman PC		0，，：	1
	9	Gemcitabine, 5-fluorouracil,and paclitaxel with concomitant radiotherapy in recurrent or advanced head and neck cancer显示文摘	Humerickhouse R Haraf D Brockstein B	2000	Cancer Invest2000，18，1：	1
	10	Quality of life and performance i n advanced head and neck cancer patients on concomitant chemoradiotherapy: A pro spective examination显示文摘	Siston A Haraf D	1999	J Clin oncol1999，17，：	1
	11	Phase Ⅰ study of docetaxel with concomitant thoracic radiation therapy显示文摘	Mauer AM Masters GA Haraf D J	1998	J Clin Oncol1998，16，1：	1
	12	Phase I study of bevacizumab added to fluorouracil - and hydroxyurea - based concomitant chemoradiotherapy for poor - prognosis head and neck cancer显示文摘	SEIWERT T Y HARAF D J COHEN E E	2008	J Clin Oncol2008，26，10：	1
	13	Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies显示文摘	PEDERSON A W SALAMA J K HARAF D J	2011	Head Neck Oncol2011，3，1：	1
	14	Patterns of fail- ure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy : a 9-year, 337 -patient, multi-institutional experience 显示文摘	Brockstein B Haraf D J Rademaker AW et at	2004	Ann On- col2004，15，8：	1
	15	Concomitant chemotherapy as primary therapy for locoregionally advanced head and neck cancer显示文摘	Vokes E E Kies M S Haraf D J	2000	J Clin Oncol2000，18，：	1
	16	The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer显示文摘	VOKES E E HARAF D J KIES M S	2000	Semin Oncol2000，27，48：	1
	17	Pilot studyexamining tumor expression of RAD51 and clinical outcomes in humanhead cancers显示文摘	CONNELL P P JAYATHILAKA K HARAF D J	2006	Int J Oncol2006，28，5：	1
	18	A phase Ⅰ-Ⅱ study of concomitant chemoradiotherapy with paclitaxel(one-hour infusion),5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer显示文摘	BROCKSTEIN B HARAF D J STENSON K et al	2000	Ann Oncol2000，11，6：	1
	19	Competing causes 05 death and second primary tumors in patients with locoregionally ad vanced head and neck cancer treated with chemoradiotherapy 显示文摘	ArgirisA Brockstein B E Haraf D J	2004	ClinCancer Res2004，10，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费